A Phase 1b study of iN1011-N17 in healthy volunteers and post-herpetic neuralgia patients

Unknown Phase 1 ACTRN12622001300763

Study Description

A study to evaluate the safety, tolerability, and pharmacological properties of an investigational drug (iN1011-N17) in healthy volunteers and patients with post-herpetic neuralgia

Study Details

Registry ID:
ACTRN12622001300763
Conditions:
Post Hepatic Neuralgia
Phase:
Phase 1
Target Enrollment:
32 participants
Start Date:
Age Range:
18–55 years
Healthy Volunteers:
No

Study Locations (1 site)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →